120 related articles for article (PubMed ID: 38387259)
21. Particle beam radiation therapy for sinonasal malignancies: Single institutional experience at the Shanghai Proton and Heavy Ion Center.
Hu W; Hu J; Huang Q; Gao J; Yang J; Qiu X; Kong L; Lu JJ
Cancer Med; 2020 Nov; 9(21):7914-7924. PubMed ID: 32977357
[TBL] [Abstract][Full Text] [Related]
22. A novel dosimetric metrics-based risk model to predict local recurrence in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.
Liao W; He J; Liu Z; Tian M; Yang J; Han J; Xiao J
Radiat Oncol; 2021 Sep; 16(1):186. PubMed ID: 34556123
[TBL] [Abstract][Full Text] [Related]
23. Mixed Photon and Carbon-Ion Beam Radiotherapy in the Management of Non-Metastatic Nasopharyngeal Carcinoma.
Hu J; Huang Q; Gao J; Hu W; Yang J; Guan X; Qiu X; Zhang W; Kong L; Lu JJ
Front Oncol; 2021; 11():653050. PubMed ID: 34367954
[TBL] [Abstract][Full Text] [Related]
24. The prognostic value of the ratio of standard uptake value of lymph node to primary tumor before treatment of locally advanced nasopharyngeal carcinoma.
Lou Y; Chen D; Lin Z; Sun J; Song L; Chen W; Zhang M; Chen Y
Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):347-356. PubMed ID: 35932312
[TBL] [Abstract][Full Text] [Related]
25. Long-term outcomes of a phase II randomized controlled trial comparing intensity-modulated radiotherapy with or without weekly cisplatin for the treatment of locally recurrent nasopharyngeal carcinoma.
Guan Y; Liu S; Wang HY; Guo Y; Xiao WW; Chen CY; Zhao C; Lu TX; Han F
Chin J Cancer; 2016 Feb; 35():20. PubMed ID: 26879049
[TBL] [Abstract][Full Text] [Related]
26. Advantages of using reduced-volume intensity modulated radiation therapy for the treatment of nasopharyngeal carcinoma: a retrospective paired study.
Liu F; Luo T; Jin T; Zhang J; Xiang Z; Yan R; Xie L; Wu X; Zhang H; Wang F; Li P; Liu L
BMC Cancer; 2019 Jun; 19(1):554. PubMed ID: 31176358
[TBL] [Abstract][Full Text] [Related]
27. RBE-weighted dose conversions for patients with recurrent nasopharyngeal carcinoma receiving carbon-ion radiotherapy from the local effect model to the microdosimetric kinetic model.
Zhang L; Wang W; Hu J; Lu J; Kong L
Radiat Oncol; 2020 Dec; 15(1):277. PubMed ID: 33302998
[TBL] [Abstract][Full Text] [Related]
28. High-dose carbon-ion based radiotherapy of primary and recurrent sacrococcygeal chordomas: long-term clinical results of a single particle therapy center.
Bostel T; Mattke M; Nicolay NH; Welzel T; Wollschläger D; Akbaba S; Mayer A; Sprave T; Debus J; Uhl M
Radiat Oncol; 2020 Aug; 15(1):206. PubMed ID: 32831113
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Oncologic Outcomes and Treatment-Related Toxicity of Carbon Ion Radiotherapy and En Bloc Resection for Sacral Chordoma.
Yolcu YU; Zreik J; Wahood W; Bhatti AUR; Bydon M; Houdek MT; Rose PS; Mahajan A; Petersen IA; Haddock MG; Ahmed SK; Laack NN; Jethwa K; Jeans EB; Imai R; Yamada S; Foote RL
JAMA Netw Open; 2022 Jan; 5(1):e2141927. PubMed ID: 34994795
[TBL] [Abstract][Full Text] [Related]
30. Establishment of prognostic factors in recurrent nasopharyngeal carcinoma patients who received salvage intensity-modulated radiotherapy: A meta-analysis.
Yue Q; Zhang M; Chen Y; Zheng D; Chen Y; Feng M
Oral Oncol; 2018 Jun; 81():81-88. PubMed ID: 29884418
[TBL] [Abstract][Full Text] [Related]
31. Plasma uric acid and tumor volume are highly predictive of outcome in nasopharyngeal carcinoma patients receiving intensity modulated radiotherapy.
Lin H; Lin HX; Ge N; Wang HZ; Sun R; Hu WH
Radiat Oncol; 2013 May; 8():121. PubMed ID: 23675829
[TBL] [Abstract][Full Text] [Related]
32. Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
Hayashi K; Yamamoto N; Karube M; Nakajima M; Matsufuji N; Tsuji H; Ogawa K; Kamada T
Radiat Oncol; 2017 May; 12(1):91. PubMed ID: 28558766
[TBL] [Abstract][Full Text] [Related]
33. Is primary tumor volume still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinoma?
Guo R; Sun Y; Yu XL; Yin WJ; Li WF; Chen YY; Mao YP; Liu LZ; Li L; Lin AH; Ma J
Radiother Oncol; 2012 Sep; 104(3):294-9. PubMed ID: 22998947
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of baseline [18F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients.
Zschaeck S; Li Y; Lin Q; Beck M; Amthauer H; Bauersachs L; Hajiyianni M; Rogasch J; Ehrhardt VH; Kalinauskaite G; Weingärtner J; Hartmann V; van den Hoff J; Budach V; Stromberger C; Hofheinz F
PLoS One; 2020; 15(7):e0236841. PubMed ID: 32730364
[TBL] [Abstract][Full Text] [Related]
35. Is maximum primary tumor diameter still a prognostic factor in patients with nasopharyngeal carcinoma treated using intensity-modulated radiotherapy?
Chen Y; Hu XF; Wang Y; Chen HY; Yang L; Liu LZ; Cui CY; Liu DS; Liang SB
BMC Cancer; 2015 Apr; 15():305. PubMed ID: 25903652
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness and toxicities of intensity-modulated radiotherapy for patients with locally recurrent nasopharyngeal carcinoma.
Chen HY; Ma XM; Ye M; Hou YL; Xie HY; Bai YR
PLoS One; 2013; 8(9):e73918. PubMed ID: 24040115
[TBL] [Abstract][Full Text] [Related]
37. Is fractionated robotic stereotactic body radiosurgery optional salvage treatment for the re-irradiation of locally recurrent nasopharyngeal carcinoma?
Dogan OY; Yaprak G; Ozyurt H; Bicakci BC; Demircioglu F; Algul E; Isik N
J Cancer Res Ther; 2022; 18(1):66-71. PubMed ID: 35381763
[TBL] [Abstract][Full Text] [Related]
38. Metabolic tumor volume and conformal radiotherapy based on prognostic PET/CT for treatment of nasopharyngeal carcinoma.
Fei Z; Chen C; Huang Y; Qiu X; Li Y; Li L; Chen T
Medicine (Baltimore); 2019 Jul; 98(28):e16327. PubMed ID: 31305420
[TBL] [Abstract][Full Text] [Related]
39. The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience.
Cai X; Du Y; Wang Z; Li P; Yu Z; Zhang Q; Zhang Z
Radiat Oncol; 2020 Aug; 15(1):209. PubMed ID: 32859234
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Value and Grading of MRI-Based T Category in Patients With Nasopharyngeal Carcinoma Without Lymph Node Metastasis Undergoing Intensity-Modulated Radiation Therapy.
Chen YP; Tang LL; Zhang WN; Mao YP; Chen L; Sun Y; Liu LZ; Li WF; Liu X; Zhou GQ; Guo R; Mai HQ; Shao JY; Lin AH; Li L; Ma J
Medicine (Baltimore); 2015 Oct; 94(43):e1624. PubMed ID: 26512556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
